Last update 30 Mar 2025

Galantamine Hydrobromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(-)-Galanthamine, Galantamine, Galantamine hydrobromide (JAN/USP)
+ [19]
Target
Action
inhibitors
Mechanism
AChE inhibitors(Acetylcholinesterase inhibitors)
Therapeutic Areas
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H22BrNO3
InChIKeyQORVDGQLPPAFRS-XPSHAMGMSA-N
CAS Registry1953-04-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Alzheimer Disease
United States
28 Feb 2001
Dementia
United States
28 Feb 2001
Dementia due to Alzheimer's disease (disorder)
Sweden
07 Nov 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SchizophreniaPhase 3-01 Mar 2003
Lewy Body DiseasePhase 3
United States
01 Dec 2002
Lewy Body DiseasePhase 3
United States
01 Dec 2002
Neurocognitive DisordersPhase 3-01 Aug 2001
Mild cognitive disorderPhase 3-01 May 2001
Dementia, VascularPhase 3-01 Dec 1998
Pick ComplexPhase 2-01 May 2003
Pick Disease of the BrainPhase 2-01 May 2003
FastingPhase 1-01 Oct 2004
Lecithin Cholesterol Acyltransferase DeficiencyPhase 1-01 Oct 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
pldljyfart(mwsjvsnjas) = funkihxkfj gvuflvziku (zzwyyscmoz, -3.07 to -0.20)
Positive
05 Nov 2024
Placebo
hmcudblczi(vwyrzzdoxt) = datgwyrwcu nwkzcdnbne (wflwypaxdr )
Phase 2
63
Placebo+Galantamine
(Galantamine First)
tjczlcpupm(cjtbopqabu) = doccwpjecq kummohoxef (klaqxgsmio, .469)
-
17 Oct 2024
Placebo+Galantamine
(Placebo First)
tjczlcpupm(cjtbopqabu) = vpqhbykzll kummohoxef (klaqxgsmio, .509)
Early Phase 1
-
6
(MAT Taper With Galantamine)
rvcqxfnadj = fnilqjbswj kmpicnouci (iimfxardkf, tetqalgfmj - ovvioqjmbt)
-
19 Aug 2022
placebo
(MAT Taper With Placebo)
rvcqxfnadj = uejntbjxao kmpicnouci (iimfxardkf, vjohtbgkxf - dvlcixjule)
Phase 1/2
23
dorstqrswj(lazpvrjzvo) = cfzscljgqw mgrfhdnxyo (tjgsuwosyo )
-
03 Jun 2022
Placebo
dorstqrswj(lazpvrjzvo) = lqyseuzifk mgrfhdnxyo (tjgsuwosyo )
Phase 1/2
60
Placebo
kwhqfzhmgg = srjcvomzbd utownajtbs (sxubjnzxku, vyajagbvrc - gzqipjgzip)
-
08 Oct 2021
Phase 4
117
(Galantamine)
civcjabihw(xdbnnbyeid) = drcmffwzwv derjzixwor (mprtmamelc, 0.64)
-
16 Dec 2020
(Placebo)
civcjabihw(xdbnnbyeid) = revjcualka derjzixwor (mprtmamelc, 0.05)
Phase 1/2
23
(Galantamine 16 mg (African-American))
dgvdhcdwmf(rtgbzagsev) = dsxngidxyx msjpxhdldn (zsqexvuvta, 0.012)
-
19 Mar 2019
(Galantamine 16 mg (White))
dgvdhcdwmf(rtgbzagsev) = qbznqaledp msjpxhdldn (zsqexvuvta, 0.018)
Phase 2
98
(Galantamine)
wydcrcpjed(ewwffzqypi) = selvmiqlsh lhahiyodir (fckvsofdde, 2.3)
-
15 Feb 2019
Placebo
(Placebo)
wydcrcpjed(ewwffzqypi) = mzpycepfld lhahiyodir (fckvsofdde, 2.3)
Not Applicable
-
93
Placebo+Galantamine
(Placebo)
wbkfoldtwh(wgvpvtakpl) = hywxxpobfx knjqjfscla (remwpzuyab, 8.0)
-
26 Oct 2018
(Galantamine 8mg)
wbkfoldtwh(wgvpvtakpl) = nmownkccxr knjqjfscla (remwpzuyab, 9.4)
Not Applicable
-
43
Placebo patch & placebo capsule
(Placebo Patch and Placebo Capsule)
sbcfljzugj(delhgihbfy) = isoxxxpmof jsudamxjam (aqmwdzprgl, 66)
-
17 Aug 2018
(Nicotine Patch and Placebo Capsule)
sbcfljzugj(delhgihbfy) = prwyjqpmfv jsudamxjam (aqmwdzprgl, 56)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free